One and half years has already passed since transcatheter aortic valve implantation (TAVI) was approved in symptomatic patients with many comorbidities and in patients who cannot undergo standard surgical aortic valve replacement due to high surgical risk. Over 100,000 TAVI procedures have been performed worldwide, while over 1,000 have been done in Japan. Though many reports have been published, there have been few regarding the Japanese population.
Generally speaking, Japanese body size is smaller than that of Europeans and Americans. Smaller access site vessel and annulus size are more likely to cause serious procedural complications such as aortic dissection and aortic root rupture.
A candidate for TAVI is likely to have many comorbidities, so comprehensive medical care by a number of specialists such as experienced cardiac surgeons, cardiologists, anesthetists, nurses and rehabilitation therapists is essential.
In this paper we would like to assess heart team management, initial treatment results, and future tasks based on our own experience.
View full abstract